Background illustration for clinical trials search

Paid Clinical Trials Washington State

Discover 1,593 paid clinical trials in Washington State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

for
Melanoma, Medullary Thyroid Cancer,
Location: Tucson AZ, Seattle WA
Sponsor: University of Arizona

Sex: All

Age: 18 - 70+

Code: NCT06814496

Phase1, Phase2, Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06943755

Phase2, Phase3, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase2, Recruiting

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Location: Saint John, Portland ME, Providence RI, Worcester MA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06679101

Phase3, Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

for
Alzheimer's Disease
Location: Valley Stream NY, Staten Island NY, Morehead City NC,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT07011745

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

for
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07046078

Phase2, Recruiting

Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial

for
Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06948786

Phase2, Recruiting

Pelacarsen Roll-over Extension Program

for
Atherosclerotic Cardiovascular Disease
Location: Richmond Hill NY, Summit NJ, New Brunswick NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06875973

Phase3, Recruiting

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Philadelphia PA, Celebration FL, Sioux Falls SD,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06803680

Phase1, Recruiting

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

for
Neovascular Age-Related Macular Degeneration (nAMD)
Location: Springfield MA, Westbury NY, New York NY, Bloomfield NJ,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 50+

Code: NCT07064759

Phase3, Recruiting

TrialNet Pathway to Prevention of T1D

for
Diabetes Mellitus, Type 1
Location: Boston MA, New Haven CT, New York NY, Toronto,
Sponsor: University of South Florida

Sex: All

Age: 2 - 45

Code: NCT00097292

Recruiting

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for
Breast Neoplasms
Location: Moncton, Westbury NY, Jamaica NY, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07060807

Phase3, Recruiting

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

for
Type 1 Diabetes (T1D), Metabolic Diseases,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18 - 69

Code: NCT07699380

Phase2, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Boston MA, Westbury NY, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase2, Recruiting

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer,
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07020221

Phase1, Phase2, Recruiting

Integrated Suicide Supports and Safety Planning for Youth

for
Suicidal Ideation, Suicidal Behavior
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 13 - 21

Code: NCT06701006

Recruiting

A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

for
Friedreich Ataxia
Location: Quebec, Montreal, Philadelphia PA, Norfolk VA, Tampa FL,
Sponsor: Biogen

Sex: All

Age: 2 - 15

Code: NCT06953583

Phase3, Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Boston MA, Quebec, Greenfield Park, Montreal, Miami FL,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase2, Recruiting

Selinexor and Backbone Treatments of Multiple Myeloma Patients

for
Multiple Myeloma
Location: Boston MA, Durham NC, Seattle WA
Sponsor: Karyopharm Therapeutics Inc

Sex: All

Age: 18+

Code: NCT02343042

Phase1, Phase2, Recruiting

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

for
Growth Hormone Deficiency (GHD)
Location: Staten Island NY, Washington D.C. DC,
Sponsor: Lumos Pharma

Sex: All

Age: 3 - 11

Code: NCT06948214

Phase3, Recruiting

Popular cities in Washington State

SpokaneBellinghamSeattleKentEverettTacomaRenton